THE EFFECT OF ROSIGLITAZONE ON OXIDATIVE STRESS AND INSULIN RESISTANCE IN OVERWEIGHT INDIVIDUALS

Phase 3

Completed

• Conditions: Obesity; Diet and Nutrition - Obesity

• Registration Number: ACTRN12606000313538
• Lead Sponsor: A/Prof PJ Manning

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-07-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Healthy individuals with BMI > 27 kg/m2.

Exclusion Criteria

Type 2 diabetes or known cardiovascular disease. Lipid lowering therapy, anti-inflammatory drugs, steroids. Recent surgery. Smoking.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oxidative stress markers[At 0, 3 and 6 months];Insulin Resistance[At 0, 3 and 6 months]

Secondary Outcome Measures

Name	Time	Method
Inflammatory markers [0, 3 and 6 months];Liver function [0, 3 and 6 months]